Jazz Pharmaceuticals plc — Director's Dealing 2010

Dec 3, 2010

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JAZZ PHARMACEUTICALS INC (JAZZ)
CIK: 0001232524
Period of Report: 2010-12-03

Reporting Person: Gamble Carol A (SVP, GC and Secretary)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-12-03	Common Stock	M	8885	$1.25	Acquired	16089	Direct
2010-12-03	Common Stock	M	16115	$7.96	Acquired	32204	Direct
2010-12-03	Common Stock	S	25000	$17.77	Disposed	7204	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2010-12-03	Option (right to buy)	$1.25	M	8885	Disposed	2019-01-20	Common Stock (8885)	Direct
2010-12-03	Option (right to buy)	$7.96	M	16115	Disposed	2018-05-15	Common Stock (16115)	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.70 to $17.90, inclusive.

F2: The reporting person undertakes to provide to Jazz Pharmaceuticals, Inc., any security holder of Jazz Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in footnote (1) to this Form 4.

F3: The options vest over three years measured from the vesting commencement date, January 21, 2009, with 1/3rd vesting on the first anniversary of the vesting commencment date and the remainder vesting in 24 equal monthly installments thereafter.

F4: The options vest over four years measured from the vesting commencement date, May 16, 2008, with 1/4th vesting on the first anniversary of the vesting commencment date and the remainder vesting in 36 equal monthly installments thereafter.